A unique webinar on Cerebral Amyloid Angiopathy emerging diagnostic advances, by people who are driving these changes in the field. No similar session has been recently presented in international conferences as such, and there is a lot of uncertainty among stroke neurologists and other clinicians around CAA diagnosis, emerging biomarkers and more rare presentations.
- Cerebral amyloid angiopathy: update on the Boston Criteria (Andreas Charidimou, USA)
- Cerebral amyloid angiopathy-related transient focal neurological episodes (Eric Smith, Canada)
- CSF and PET biomarkers for cerebral amyloid angiopathy diagnosis (Gargi Banerjee, UK)